Ghrelin News and Research

RSS
Ghrelin is a hormone produced mainly by P/D1 cells lining the fundus of the human stomach and epsilon cells of the pancreas that stimulates appetite. Ghrelin levels increase before meals and decrease after meals. It is considered the counterpart of the hormone leptin, produced by adipose tissue, which induces satiation when present at higher levels. Ghrelin is also produced in the hypothalamic arcuate nucleus where it stimulates the secretion of growth hormone from the anterior pituitary gland.
Sleep-deprived people may buy more high-calorie foods the following day

Sleep-deprived people may buy more high-calorie foods the following day

Study: People who are deprived of sleep purchase more food on following day

Study: People who are deprived of sleep purchase more food on following day

Glucagon loses its ability to help obese people, but continues to suppress hunger pangs

Glucagon loses its ability to help obese people, but continues to suppress hunger pangs

Health benefits of sufficient sleep: an interview with Dr Monique Verschuren, National Institute for Public Health and the Environment, the Netherlands

Health benefits of sufficient sleep: an interview with Dr Monique Verschuren, National Institute for Public Health and the Environment, the Netherlands

High-calorie breakfast protects against diabetes, hypertension and cardiovascular problems

High-calorie breakfast protects against diabetes, hypertension and cardiovascular problems

Alize Pharma initiates AZP-531 Phase I clinical trial for treatment of type 2 diabetes

Alize Pharma initiates AZP-531 Phase I clinical trial for treatment of type 2 diabetes

Study shows link between FTO, ghrelin and impaired brain food-cue responsivity

Study shows link between FTO, ghrelin and impaired brain food-cue responsivity

Coffee and appetite: an interview with Matt Schubert and Associate Professor Ben Desbrow, Griffith University

Coffee and appetite: an interview with Matt Schubert and Associate Professor Ben Desbrow, Griffith University

NIH awards $12.7M to research groups to explore new treatments for patients in eight disease areas

NIH awards $12.7M to research groups to explore new treatments for patients in eight disease areas

Surefire Infusion System to be used for obesity treatment

Surefire Infusion System to be used for obesity treatment

Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

Rhythm starts RM-131 Phase 2 clinical trial for treatment of chronic constipation

Timing of meals predicts weight-loss effectiveness

Timing of meals predicts weight-loss effectiveness

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

Rhythm commences RM-493 Phase 2 trial in obesity

Rhythm commences RM-493 Phase 2 trial in obesity

Top 4 reasons why many dieters do not lose weight

Top 4 reasons why many dieters do not lose weight

Oxnard-based couple receives gastric sleeve surgeries from leading L.A. expert

Oxnard-based couple receives gastric sleeve surgeries from leading L.A. expert

Study points to complexity of relationship between sleep duration and energy balance regulation

Study points to complexity of relationship between sleep duration and energy balance regulation

Rhythm raises additional $8 million to complete Series B financing

Rhythm raises additional $8 million to complete Series B financing

Some types of bariatric surgery may cause bone loss, say endocrinologists

Some types of bariatric surgery may cause bone loss, say endocrinologists